GC Corp. (KRX:005250)

Market Cap	631.08B +7.3%
Revenue (ttm)	2.45T +11.2%
Net Income	-69.51B
EPS	-1,531.00
Shares Out	45.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	300.00 (2.11%)
Ex-Dividend Date	Mar 30, 2026

Volume	78,647
Average Volume	90,931
Open	14,250
Previous Close	14,210
Day's Range	13,910 - 14,250
52-Week Range	13,240 - 17,700
Beta	0.62
RSI	45.62
Earnings Date	Apr 3, 2026

About GC Corp.

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250